Mechanism of the inhibitory effect of tranexamic acid on melanogenesis in cultured human melanocytes in the presence of keratinocyte-conditioned medium

Journal of Health Science

Volumn 53, Issue 4, 2007, Pages 389-396

  Maeda, Kazuhisa ^a,c   Tomita, Yasushi ^b  

^a SHISEIDO RESEARCH CENTER   (Japan)

^b NAGOYA UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^c TOKYO UNIVERSITY OF TECHNOLOGY   (Japan)

Author keywords

Depigmentation; Melanocytes; Melasma; Tranexamic acid; Urokinase type plasminogen activator

Indexed keywords

MELANIN; MONOPHENOL MONOOXYGENASE; PLASMIN; PLASMINOGEN ACTIVATOR INHIBITOR; TRANEXAMIC ACID; UROKINASE;

ARTICLE; CELL ACTIVATION; CELL CULTURE; CELL STRUCTURE; CONCENTRATION RESPONSE; CONTROLLED STUDY; CULTURE MEDIUM; DRUG EFFECT; ENZYME ACTIVITY; ENZYME INHIBITION; HUMAN; HUMAN CELL; KERATINOCYTE; MELANOCYTE; MELANOGENESIS; MOLECULAR WEIGHT;

EID: 34547591123     PISSN: 13449702     EISSN: 13475207     Source Type: Journal    
DOI: 10.1248/jhs.53.389     Document Type: Article

References (34)

1. Perez, M., Sanchez, J. L. and Aguilo, F. (1983) Endocrinologic profile of patients with idiopathic melasma. J. Invest. Dermatol., 81, 543-545.
2. Hassan, I., Kaur, I., Sialy, R. and Dash, R. J. (1998) Hormonal milieu in the maintenance of melasma in fertile women. J. Dermatol., 25, 510-512.
3. Grimes, P. E. (1995) Melasma. Etiologic and therapeutic considerations. Arch. Dermatol., 131, 1453-1457.
4. Verallo-Rowell, V. M., Verallo, V., Graupe, K., Lopez-Villafuerte, L. and Garcia-Lopez, M. (1989) Double-blind comparison of azelaic acid and hydroquinone in the treatment of melasma. Acta Derm. Venereol. Suppl. (Stockh.), 143, 58-61.
5. Hurley, M. E., Guevara, I. L., Gonzales, R. M. and Pandya, A. G. (2002) Efficacy of glycolic acid peels in the treatment of melasma. Arch. Dermatol., 138, 1578-1582.
6. Higashi, N. (1988) Treatment of melasma with oral tranexamic acid. Skin Res., 30, 676-680 (in Japanese).
7. Higashi, N. (1993) Treatment of melasma. Rinsho Hifuka, 47 (5 supple.), 149-152 (in Japanese).
8. Isseroff, R. R. and Rifkin, D. B. (1983) Plasminogen is present in the basal layer of the epidermis. J. Invest. Dermatol., 80, 297-299.
9. Jensen, P. J., John, M. and Baird, J. (1990) Urokinase and tissue type plasminogen activators in human keratinocyte culture. Exp. Cell Res., 187, 162-169.
10. Peterson, R. A., Krull, P. E., Finley, P. and Ettinger, M. G. (1970) Changes in antithrombin 3 and plasminogen induced by oral contraceptives. Am. J. Clin. Pathol., 53, 468-473.
11. Hashimoto, K., Prystowsky, J. H., Baird, J., Lazarus, G. S. and Jensen, P. J. (1988) Keratinocyte urokinase-type plasminogen activator is secreted as a single chain precursor. J. Invest. Dermatol., 90, 823-828.
12. Green, H. (1977) Terminal differentiation of cultured human epidermal cells. Cell, 11, 418-423.
13. Morioka, S., Lazarus, G., Baird, J. L. and Jansen, P. J. (1987) Migrating keratinocytes express urokinase-type plasminogen activator. J. Invest. Dermatol., 88, 418-423.
14. Hashimoto, K., Horikoshi, T., Nishioka, K., Yoshioka, K. and Carter, D.M. (1986) Plasminogen activator secreted by cultured human melanocytes. Br. J. Dermatol., 115, 205-209.
15. Tomita, Y., Montague, P. M. and Hearing, V. J. (1985) Anti-T4-tyrosinase monoclonal antibodies-specific markers for pigmented melanocytes. J. Invest. Dermatol., 85, 426-430.
16. Jackson, I. J. (1988) cDNA encoding tyrosinase-related protein maps to brown locus in mouse. Proc. Natl. Acad. Sci. U.S.A., 85, 4392-4396.
17. Maeda, K., Tomita, Y., Fukuda, M. and Tagami, H. (1992) Effects of staurosporine, PMA and A23187 on human melanocyte cultures with dibutyryl cyclic AMP. Br. J. Dermatol., 126, 118-124.
18. Maeda, K. and Fukuda, M. (1996) Arbutin: mechanism of its depigmenting action in human melanocyte culture. J. Pharmacol. Exp. Ther., 276, 765-769.
19. The Minister of Health, Labour and Welfare, Tranexamic acid. In The Japanese Pharmacopoeia Fourteenth Edition, Hirokawa Publishing, Tokyo, pp.C-2041-C-2046.
20. Abiko, Y. and Iwamoto, M. (1970) Plasminogen-plasmin system VII. Biochim. Biophys. Acta, 214, 411-418.
21. Li, C., Liu, J. N. and Gurewich, V. (1995) Urokinase-type plasminogen activator-induced monocyte adhesion requires a carboxyl-terminal lysine and cAMP-dependent signal transduction. J. Biol. Chem., 270, 30282-30285.
22. Blasi, F., Stoppelli, M. and Cubellis, M. V. (1986) The receptor for urokinase-plasminogen activator. J. Cell Biochem., 32, 179-186.
23. Appela, E., Robinson, E. A., Ullrich, J. U., Stoppelli, M. P., Corti, A., Cassani, G. and Blasi, F. (1987) The receptor-binding sequence of urokinase. A biological function for the growth-factor module of proteases. J. Biol. Chem., 262, 4437-4440.
24. Grimaldi, G., Di Fiore, P. P., Kajtaniak, E. L., Falco, J. and Blasi, F. (1986) Modulation of urokinase plasminogen activator gene expression during the transition from quiescent to proliferative state in normal mouse cells. EMBO J., 5, 855-861.
25. 2 into receptor binding, active forms. Biochem. Biophys. Res. Commun., 198, 10-15.
26. Tomita, Y., Maeda, K. and Tagami, H. (1992) Melanocyte-stimulating properties of arachidonic acid metabolites: possible role in postinflammatory pigmentation. Pigment Cell Res., 5, 357-361
27. 2 stimulate normal human melanocytes in vitro: possible inducers of post-inflammatory pigmentation. Tohoku J. Exp. Med., 156, 303-304.
28. Falcone, D. J., McCaffrey, T. A., Haimovitz-Friedman, A., Vergilio, J. A. and Nicholson, A. C. (1993) Macrophage and foam cell release of matrix-bound growth factors. Role of plasminogen activation. J. Biol. Chem., 268, 11951-11958.
29. Syrovets, T., Jendrach, M., Rohwedder, A., Schüle, A. and Simmet, T. (2001) Plasmin-induced expression of cytokines and tissue factor in human monocytes involves AP-1 and IKK-mediated NF-κB activation. Blood, 97, 3941-3950.
30. Burysek, L., Syrovets, T. and Simmet, T. (2002) The serine protease plasmin triggers expression of MCP-1 and CD40 in human primary monocytes via activation of p38 MAPK and Janus kinase (JAK)/STAT signaling pathways. J. Biol. Chem., 277, 33509-33517.
31. Matsumura, Y., Takada, K., Murakami, A., Takaoka, M. and Morimoto, S. (1996) Plasmin stimulates expression of endothelin-1 mRNA and endothelin-1 release in vascular endothelial cells. Life Sci., 58, 1067-1074.
32. Naldini, L., Tamagnone, L., Vigna, E., Sachs, M., Hartmann, G., Birchmeier, W., Daikuhara, Y., Tsubouchi, H., Blasi, F. and Comoglio, P.M. (1992) Extracellular proteolytic cleavage by urokinase is required for activation of hepatocyte growth factor/scatter factor. EMBO J., 11, 4825-4833.
33. Im, S., Kim, J., On, W. Y. and Kang, W. H. (2002) Increased expression of alpha-melanocyte-stimulating hormone in the lesional skin of melasma. Br. J. Dermatol., 146, 165-167.
34. Kang, H. Y., Hwang, J. S., Lee, J. Y., Ahn, J. H., Kim, J. Y., Lee, E. S. and Kang, W. H. (2006) The dermal stem cell factor and c-kit are overexpressed in melasma. Br. J. Dermatol., 154, 1094-1099.